IS COMING WORLD CURRENCY ON US PATIENTS?

IS COMING WORLD CURRENCY ON US PATIENTS?

420 and dont kill my buzzContinuing our look into the world of GMO pot, we have so far; experimentation, infiltration of well-funded grows into legal mainstreams, secret government GMO pot programs, and the ‘no’ no-GMO wording being put through by the oily glad-hand tactics of the DPA. The plan seems simple enough; outproduce the competition, corner the market, get people hooked on bad pot, and double dip by also taxing the addiction. But what if I told you that was just the tip of the iceberg?

As you look through the following list, think of how many sick people there are who are helped by cannabis, and remember, you can’t patent a plant, but you can an addictive drug.

How much money is involved in Obama’s MarijuanaGate? Potentially trillions.

Once again our star reporter Laurie Canadian420, a 420Nurse, has sourced this next piece in this fascinating government sellout of America.

We have known about the patent for neuroprotection and anti-oxidants pot patent(1)related to CBD for years now. The Federal Government patented CBD for this and other potential health benefits. The US Patent #6630507, is seen pictured here and used in a number of Calendar stories also.

However shown below are the one and forty-two various patents granted on GMO pot. With patent royalties coming in, a very Bill Clinton style move, Obama won’t need any bitch miles for traveling, or have to take speaking engagements. Really is a chip off the old Cheney, as you don’t see him speaking anywhere either, outside of Dubai.

2304669 1942 Isolation of cannabidiol – 20110217.005017

2354492 1944 Marihuana active compound – 20110217.005419

2419934 1947 Optically active tetrahydrodibenzopyrans having marihuana activity and process for .. – 20110217.010128

2419935 1947 Marihuana active compounds – 20110217.010934

2419936 1947 Preparation of compounds with marihuana activity – 20110217.011517

2509386 1950 Dibenzopyran marihuana-like compounds – 20110217.012129

2509387 1950 Dibenzopyran marihuana-like compounds – 20110217.012513

3668224 1972 Process of producing 6a, 10a-trans-6a,7,8,10a-tetrahydrodibenzo (b,d)-pyrans – 20110217.013244

3728360 1973 Ester derivatives of tetrahydrocannabinol – 20110217.013646

3734930 1973 Direct synthesis of (-)-trans-delta-9-tetrahydrocannabinol from olivetol and (+)-tr.. – 20110217.005434

4025516 1977 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. – 20110217.022419

4116979 1978 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. – 20110217.030800

4126694 1978 Composition and method for treating glaucoma – 20110217.031302

4126695 1978 Anti-glaucoma composition and method – 20110217.031624

4179517 1979 Novel tetrahydrocannabinol type compounds – 20110217.032121

4189491 1980 Tetrahydrocannabinol in a method of treating glaucoma – 20110217.032351

4195078 1980 Nabilone granulation – 20110219.131638

4279824 1981 Method and apparatus for processing herbaceous plant materials including the plant .. – 20110221.005824

4315862 1982 Process for preparing cannabichromene – 20110219.132528

4327028 1982 Composition of matter – 20110219.132854

4464378 1984 Method of administering narcotic antagonists and analgesics – 20110219.134318

4476140 1984 Composition and method for treatment of glaucoma – 20110219.133925

4758597 1988 Carenadiol and derivatives – 20110220.235422

4837228 1989 Antiinflammatory and antimicrobial compounds and compositions – 20110219.135422

4847290 1989 Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents – 20110219.140914

4876276 1989 (3s-4s)-7-hydroxy-delta-6-tetrahydrocannabinols – 20110219.141600

4933363 1990 Method for effecting systemic delivery of delta-9-tetrahydrocannabinol – 20110219.144031

5227537 1993 Method for the production of 6,12-dihydro-6-hydroxy-cannabidiol and the use thereof.. – 20110221.005135

5237057 1993 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. – 20110219.144538

5292899 1994 Synthesis of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid glucuronide – 20110219.145249

5302703 1994 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. – 20110219.145809

5338753 1994 (3r,4r)-delta-6-tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents .. – 20110219.150617

5342971 1994 Process for the preparation of dibenzo[b,d]pyrans – 20110219.150655

5389375 1995 Stable suppository formulations effecting bioavailability of delta-9-thc – 20110219.151015

5440052 1995 Compositions useful as a cannabinoid receptor probe – 20110219.151453

5508037 1996 Stable suppository formulations effecting bioavailability of delta-9-thc – 20110219.151931

5532237 1996 Indole derivatives with affinity for the cannabinoid receptor – 20110219.152606

5538993 1996 Certain tetrahydrocannabinol-7-oic acid derivatives – 20110219.152901

5596106 1997 Cannabinoid receptor antagonists – 20110219.153207

5605906 1997 Cannabinoid receptor agonists – 20110219.153325

5605928 1997 Antiemetic compositions – 20110219.153523

5631297 1997 Anandamides useful for the treatment of intraocular hypertension… – 20110219.160906

5635530 1997 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processor.. – 20110219.154139

5688825 1997 Anandamide amidase inhibitors as analgesic agents – 20110219.161202

5716638 1998 Composition for applying active substances to or through the skin – 20110219.161548

5747524 1998 Cannabinoid receptor antagonists – 20110219.161846

5804592 1998 Method for improving disturbed behavior and elevating mood in humans – 20110219.162419

5847128 1998 Water soluble derivatives of cannabinoids – 20110219.162859

5872148 1999 Compositions useful as a cannabinoid receptor probe – 20110219.163222

5874459 1999 Anandamide amidase inhibitors as analgesic agents – 20110219.163805

5925768 1999 pyrazolecarboxamide derivatives having cannabinoid receptor affinity – 20110219.164326

5932610 1999 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals – 20110219.164744

5939429 1999 Cardiovascular uses of cannabinoid compounds – 20110219.164958

5948777 1999 Cannabinoid receptor agonists – 20110219.165232

5977180 1999 Anandamide analog compositions and method of treating intraocular hypertension usin.. – 20110219.165507

5990170 1999 Therapeutic use of mono and bicarboxylic acid amides active at the peripheral canna.. – 20110219.165901

6008383 1999 Method of preparing delta-9-tetrahydrocannabinol esters – 20110219.170127

6013648 2000 Cb2 receptor agonist compounds – 20110219.170359

6017919 2000 Compounds and pharmaceutical use thereof – 20110219.232239

6096740 2000 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions – 20110219.232844

6100259 2000 Cannabinoid receptor modulators – 20110219.233213

6113940 2000 Cannabinoid patch and method for cannabis transdermal delivery – 20110219.233850

6132762 2000 Transcutaneous application of cannabis – 20110219.234036

6162829 2000 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. – 20110219.234311

6166066 2000 Cannabinoids selective for the cb2 receptor – 20110219.234631

6274635 2001 Alkylated resorcinol derivatives for the treatment of immune diseases – 20110219.235354

6284788 2001 Use of known agonists of the central cannabinoid receptor cb1 – 20110219.235654

6328992 2001 Cannabinoid patch and method for cannabis transdermal delivery – 20110220.000814

6331560 2001 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals – 20110220.002503

6344474 2002 Use of central cannabinoid receptor antagonists for regulating appetence – 20110220.002717

6355650 2002 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. – 20110220.002953

6380175 2002 Method for enhancement of delivery of thc by the administration of its prodrugs via.. – 20110220.003309

6383513 2002 Compositions comprising cannabinoids – 20110220.003536

6391909 2002 Anandamide inhibitors as analgesic agents – 20110220.003752

6448288 2002 Cannabinoid drugs – 20110220.004111

6509005 2003 delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhaler – 20110220.010440

6509367 2003 Pyrazole cannabinoid agonist and antagonists – 20110220.010824

6545041 2003 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals – 20110220.011159

6563009 2003 Vasodilator cannabinoid analogs – 20110220.011723

6566560 2003 Resorcinolic compounds – 20110220.012340

6579900 2003 Anandamide amidase inhibitors as analgesic agents – 20110220.013014

6610737 2003 Non psychotropic cannabinoids – 20110220.013607

6630507 2003 Cannabinoids as antioxidants and neuroprotectants – 20110217.040403

6642258 2003 Use of central cannabinoid receptor antagonist for preparing medicines-20110220.141047

6653304 2003 Cannabinoid receptor modulators, their processes of preparation, and use of cannabi.. – 20110220.141700

6703418 2004 Appetite stimulation and induction of weight gain in patients suffering from sympto.. – 20110220.141926

6713048 2004 Delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhalers and metho.. – 20110220.142152

6747058 2004 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol a.. – 20110220.142350

6825209 2004 Compounds having unique cb1 receptor binding selectivity and methods for their prod.. – 20110220.142627

6864291 2005 Agonists specific for the peripheral cannabinoid receptor – 20110220.142827

6900236 2005 Cannabimimetic indole derivatives – 20110220.143112

6903137 2005 Agonists specific for the peripheral cannabinoid receptor – 20110220.144738

6930122 2005 Use of central cannabinoid receptor antagonist for preparing medicines designed to .. – 20110220.225951

6939977 2005 Analgesic and immunomodulatory cannabinoids – 20110220.230157

6943266 2005 Bicyclic cannabinoid agonists for the cannabinoid receptor – 20110220.230355

6949582 2005 Method of relieving analgesia and reducing inflamation using a cannabinoid delivery.. – 20110220.230551

6974568 2005 Treatment for cough – 20110220.231124

6995187 2006 Peripheral cannabinoid receptor (cb2) selective ligands – 20110220.231316

7049329 2006 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof – 20110220.231649

7057076 2006 Bicyclic and tricyclic cannabinoids – 20110220.231942

7067539 2006 Cannabinoid receptor ligands – 20110220.232124

7071213 2006 Cannabinoid receptor ligands – 20110220.232329

7088914 2006 Device, method and resistive element for vaporizing a medicament – 20110220.232627

7105685 2006 Cannabinol derivatives – 20110220.232801

7109245 2006 Vasoconstrictor cannabinoid analogs – 20110220.233007

7119108 2006 Pyrazole derivatives as cannabinoid receptor antagonists – 20110220.233254

7129239 2006 Purine compounds and uses thereof – 20110220.233510

7141669 2006 Cannabiniod receptor ligands and uses thereof – 20110220.233811

7145012 2006 Cannabinoid receptor ligands and uses thereof – 20110220.234023

7161016 2007 Cannabimimetic lipid amides as useful medications – 20110220.234200

7169942 2007 Cannabinoid derivatives, methods of making, and use thereof – 20110220.234343

7173027 2007 Receptor selective cannabimimetic aminoalkylindoles – 20110220.234621

7176210 2007 Cannabinoid receptor ligands and uses thereof – 20110220.234841

7179800 2007 Cannabinoids – 20110220.235606

7183313 2007 Keto cannabinoids with therapeutic indications – 20110220.235821

7217732 2007 Cannabinoid receptor agonists – 20110221.000020

7220743 2007 Heterocyclic cb1 receptor antagonists – 20110221.000208

7229999 2007 Pyridine-3-carboxamide derivatives as cb1 inverse agonists – 20110221.000408

7232823 2007 Cannabinoid receptor ligands and uses thereof – 20110221.000602

7235584 2007 Non psychotropic cannabinoids – 20110221.000739

7241799 2007 Cannabimimetic indole derivatives – 20110221.000920

7247628 2007 Cannabinoid receptor ligands and uses thereof – 20110221.001058

7268133 2007 Cannabinoid receptor ligands and uses thereof – 20110221.001308

7276516 2007 Cb1 antagonist compounds – 20110221.002759

7276613 2007 Retro-anandamides, high affinity and stability cannabinoid receptor ligands – 20110221.002935

7285683 2007 Bicyclic and tricyclic cannabinoids – 20110221.003404

7285687 2007 Cannabinoids – 20110221.003830

7294644 2007 Cb 1 receptor inverse agonists – 20110221.004028

7321047 2008 Separation of tetrahydrocannabinols – 20110221.004243

7323576 2008 Synthetic route to dronabinol – 20110221.004441

7329651 2008 Cannabimimetic ligands – 20110221.004633

7329658 2008 Cannabinoid receptor ligands and uses thereof – 20110221.004825

7335688 2008 Bicyclic cannabinoid agonists for the cannabinoid receptor – 20110221.005006

7344736 2008 Extraction of pharmaceutically active components from plant materials – 20110221.005455

7354929 2008 Cannabinoid receptor ligands and uses thereof – 20110221.010029

7358245 2008 Treatment of gastroesophageal reflux disease – 20110221.010322

7393842 2008 Pyrazole analogs acting on cannabinoid receptors – 20110221.010732

7399872 2008 Conversion of CBD to delta-8-thc and delta-9-thc – 20110221.011142

7402686 2008 Cannabinoid crystalline derivatives and process of cannabinoid purification – 20110221.011644

7592328 2009 Natural cyclodextrin complexes – 20110221.011900

7592468 2009 Production of delta-9 tetrahydrocannabinol – 20110221.012444

7648696 2010 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous.. – 20110221.012955

 

Besides selling a subsidized Monsanto GMO seed variety as a monopoly reaping the benefits from taxes and profit with an addictive product like cigarettes, with all the sick people created as a growing population money made from the patents will keep the debt ceiling up until the population collapses, not the currency.

The reason for treason in MarijuanaGate, it’s out there if you look.

 

(Story source – by Allan Frankel, http://www.greenbridgemed.com/2011/06/19/cannabis-so-many-legal-federal-patents-and-still-a-useless-medication/)

 

2 comments
PT Rothschild
CHIEF_EDITOR
PROFILE

Posts Carousel

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

2 Comments

Latest Posts

Top Authors

Most Commented

Featured Videos